跳至主要内容
临床试验/NCT00994513
NCT00994513已完成2 期

Effect of Alpha Lipoic Acid on Obesity Related Comorbidities

Augusta University1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2009年7月最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
70
试验地点
1
主要终点
Biomarkers of oxidative stress

研究概览

简要总结

The major objective of this study is to conduct a double-blind, placebo-controlled, randomized clinical trial to assess whether oral alpha lipoic acid supplementation will decrease cardiovascular disease and type 2 diabetes risk in obese subjects.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Han ethnicity
  • BMI≥25kg/m2
  • Having at least one of the following risk factors: borderline hypertension (130mmHg≤SBP<140mmHg or 85mmHg≤DBP<90mmHg), dyslipidemia (fasting total cholesterol ≥240mg/dl or HDL-C<40mg/dl), or impaired fasting glucose (fasting glucose levels between 6.1 and 7.0mmol/L)
  • 18-60 years old
  • Not on any antioxidant vitamin supplement

排除标准

  • Pregnancy, lactation or child-bearing age without birth control device
  • History of hypertension, diabetes, coronary heart disease(CHD), cancer or liver disease
  • Anything that would impede the subject from complying with the ALA treatment
  • History of psychiatric problems

结局指标

主要结局

Biomarkers of oxidative stress

时间窗: 2 months

Insulin sensitivity

时间窗: 2 months

Endothelial function

时间窗: 2 months

次要结局

  • Inflammatory markers(2 months)
  • Blood pressure(2 months)
  • Fasting lipid profile(2 months)
  • Pulse wave velocity(2 months)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验